(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1604974 6480464 epigallocatechin gallate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of SLC51A mRNA], epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA] CTD PMID:22178739 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLC51A mRNA] CTD PMID:23146761 (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of SLC51A mRNA CTD PMID:23146761 1,2-dichloroethane decreases expression ISO RGD:1322376 6480464 ethylene dichloride results in decreased expression of SLC51A mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1322376 6480464 1, 2-Dimethylhydrazine results in decreased expression of OSTA mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:1322376 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC51A mRNA CTD PMID:28549656 , PMID:30517764 17alpha-ethynylestradiol affects expression ISO RGD:1322376 6480464 Ethinyl Estradiol affects the expression of SLC51A mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC51A mRNA CTD PMID:23146761 17alpha-ethynylestradiol multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLC51A mRNA] CTD PMID:23146761 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC51A mRNA CTD PMID:28522335 8-Br-cAMP increases expression ISO RGD:1604974 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC51A mRNA CTD PMID:22079614 acrylamide increases expression ISO RGD:1604974 6480464 Acrylamide results in increased expression of SLC51A mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1604974 6480464 Aflatoxin B1 results in decreased expression of SLC51A mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1604974 6480464 Aflatoxin B1 results in decreased methylation of SLC51A intron CTD PMID:30157460 alfacalcidol increases expression ISO RGD:1322376 6480464 alfacalcidol results in increased expression of SLC51A mRNA CTD PMID:19581390 all-trans-retinoic acid increases expression ISO RGD:1322376 6480464 Tretinoin results in increased expression of SLC51A mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:1604974 6480464 Tretinoin results in increased expression of SLC51A mRNA CTD PMID:33167477 amoxicillin increases expression ISO RGD:1604974 6480464 Amoxicillin results in increased expression of SLC51A mRNA CTD PMID:34767876 atazanavir sulfate multiple interactions ISO RGD:1604974 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA CTD PMID:32152650 Augmentin decreases expression ISO RGD:1604974 6480464 Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA CTD PMID:34767876 benzo[a]pyrene decreases methylation ISO RGD:1604974 6480464 Benzo(a)pyrene results in decreased methylation of SLC51A exon, Benzo(a)pyrene results in decreased methylation of SLC51A promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1604974 6480464 Benzo(a)pyrene results in decreased expression of SLC51A mRNA CTD PMID:32234424 benzo[e]pyrene decreases methylation ISO RGD:1604974 6480464 benzo(e)pyrene results in decreased methylation of SLC51A intron CTD PMID:30157460 beta-hexachlorocyclohexane decreases expression ISO RGD:1322376 6480464 beta-hexachlorocyclohexane results in decreased expression of SLC51A mRNA CTD PMID:28392238 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC51A mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1604974 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC51A gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:1604974 6480464 bisphenol A results in decreased methylation of SLC51A gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1604974 6480464 bisphenol A results in increased expression of SLC51A mRNA CTD PMID:31715268 bisphenol A affects expression ISO RGD:1604974 6480464 bisphenol A affects the expression of SLC51A mRNA CTD PMID:30903817 bosentan increases expression ISO RGD:1604974 6480464 Bosentan results in increased expression of SLC51A mRNA CTD PMID:29761207 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC51A mRNA CTD PMID:32479839 budesonide increases expression ISO RGD:1604974 6480464 Budesonide results in increased expression of SLC51A mRNA CTD PMID:19562681 budesonide multiple interactions EXP 6480464 [Budesonide binds to NR3C1 protein] which results in increased expression of SLC51A mRNA CTD PMID:19562681 buta-1,3-diene decreases expression ISO RGD:1322376 6480464 1, 3-butadiene results in decreased expression of SLC51A mRNA CTD PMID:21147608 calcitriol multiple interactions ISO RGD:1604974 6480464 [Calcitriol co-treated with Chenodeoxycholic Acid] results in decreased expression of SLC51A mRNA CTD PMID:19562681 calcitriol decreases expression ISO RGD:1604974 6480464 Calcitriol results in decreased expression of SLC51A mRNA CTD PMID:16002434 , PMID:19562681 captan increases expression ISO RGD:1322376 6480464 Captan results in increased expression of SLC51A mRNA CTD PMID:31558096 chenodeoxycholic acid multiple interactions ISO RGD:1604974 6480464 7-hydroxytheonellasterol inhibits the reaction [Chenodeoxycholic Acid inhibits the reaction [NCOR1 protein binds to SLC51A promoter]] more ... CTD PMID:16423920 more ... chenodeoxycholic acid increases expression ISO RGD:1322376 6480464 Chenodeoxycholic Acid results in increased expression of SLC51A mRNA CTD PMID:25582706 chenodeoxycholic acid multiple interactions EXP 6480464 [Chenodeoxycholic Acid binds to NR1H4 protein] which results in increased expression of SLC51A mRNA CTD PMID:19562681 chenodeoxycholic acid increases expression ISO RGD:1604974 6480464 Chenodeoxycholic Acid results in increased expression of SLC51A mRNA, Chenodeoxycholic Acid results in increased expression of SLC51A protein CTD PMID:16423920 more ... cholic acid increases expression ISO RGD:1604974 6480464 Cholic Acid results in increased expression of SLC51A mRNA CTD PMID:25055961 cholic acid increases expression ISO RGD:1322376 6480464 Cholic Acid results in increased expression of SLC51A mRNA CTD PMID:25582706 cisplatin increases response to substance ISO RGD:1604974 6480464 SLC51A results in increased susceptibility to Cisplatin CTD PMID:21755009 clavulanic acid decreases expression ISO RGD:1604974 6480464 Clavulanic Acid results in decreased expression of SLC51A mRNA CTD PMID:34767876 clavulanic acid multiple interactions ISO RGD:1604974 6480464 Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA] CTD PMID:34767876 copper(II) sulfate decreases expression ISO RGD:1604974 6480464 Copper Sulfate results in decreased expression of SLC51A mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1604974 6480464 Cyclosporine results in decreased expression of SLC51A mRNA CTD PMID:25562108 , PMID:27989131 DDE decreases expression ISO RGD:1322376 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC51A mRNA CTD PMID:28392238 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC51A mRNA CTD PMID:23914054 deoxycholic acid increases expression ISO RGD:1604974 6480464 Deoxycholic Acid results in increased expression of SLC51A, Deoxycholic Acid results in increased expression of SLC51A mRNA CTD PMID:22268002 , PMID:25055961 deoxycholic acid multiple interactions ISO RGD:1604974 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA CTD PMID:32152650 deoxycholic acid increases expression ISO RGD:1322376 6480464 Deoxycholic Acid results in increased expression of SLC51A mRNA CTD PMID:25582706 deoxycholic acid multiple interactions ISO RGD:1322376 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in decreased expression of SLC51A mRNA] CTD PMID:21914718 deoxycholic acid decreases expression ISO RGD:1322376 6480464 Deoxycholic Acid results in decreased expression of SLC51A mRNA CTD PMID:21914718 deoxynivalenol decreases expression ISO RGD:1604974 6480464 deoxynivalenol results in decreased expression of SLC51A mRNA CTD PMID:35224661 dexamethasone multiple interactions EXP 6480464 [Dexamethasone binds to NR3C1 protein] which results in increased expression of SLC51A mRNA CTD PMID:19562681 dexamethasone affects expression ISO RGD:1604974 6480464 Dexamethasone affects the expression of SLC51A mRNA CTD PMID:19562681 dextran sulfate multiple interactions ISO RGD:1322376 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51A mRNA CTD PMID:29950665 dioxygen multiple interactions ISO RGD:1604974 6480464 Chenodeoxycholic Acid promotes the reaction [Oxygen deficiency results in increased expression of SLC51A mRNA] more ... CTD PMID:24703425 dioxygen increases expression ISO RGD:1604974 6480464 Oxygen deficiency results in increased expression of SLC51A mRNA, Oxygen deficiency results in increased expression of SLC51A protein CTD PMID:24703425 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SLC51A mRNA CTD PMID:25152437 epoxiconazole affects expression ISO RGD:1322376 6480464 epoxiconazole affects the expression of SLC51A mRNA CTD PMID:35436446 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SLC51A mRNA CTD PMID:30307764 fidaxomicin multiple interactions ISO RGD:1604974 6480464 Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake of Glycochenodeoxycholic Acid] more ... CTD PMID:32294204 fipronil increases expression EXP 6480464 fipronil results in increased expression of SLC51A mRNA CTD PMID:31881178 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC51A mRNA CTD PMID:24793618 folpet increases expression ISO RGD:1322376 6480464 folpet results in increased expression of SLC51A mRNA CTD PMID:31558096 fulvestrant multiple interactions ISO RGD:1604974 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC51A gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of SLC51A mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC51A mRNA CTD PMID:33387578 glycochenodeoxycholic acid multiple interactions ISO RGD:1604974 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA more ... CTD PMID:32152650 , PMID:32294204 glycocholic acid multiple interactions ISO RGD:1604974 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA more ... CTD PMID:32152650 , PMID:32294204 glycodeoxycholic acid multiple interactions ISO RGD:1604974 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA, [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51A mRNA CTD PMID:32152650 GW 4064 multiple interactions ISO RGD:1604974 6480464 Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA], epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA] CTD PMID:22178739 , PMID:34767876 GW 4064 increases expression ISO RGD:1322376 6480464 GW 4064 results in increased expression of SLC51A mRNA CTD PMID:26655953 , PMID:27609522 GW 4064 multiple interactions ISO RGD:1322376 6480464 [GW 4064 co-treated with Dietary Fats] results in decreased expression of SLC51A mRNA more ... CTD PMID:20091679 , PMID:28223344 GW 4064 increases expression ISO RGD:1604974 6480464 GW 4064 results in increased expression of SLC51A mRNA CTD PMID:22178739 more ... hydrogen peroxide affects expression ISO RGD:1604974 6480464 Hydrogen Peroxide affects the expression of SLC51A mRNA CTD PMID:20044591 imipenem hydrate multiple interactions ISO RGD:1322376 6480464 [Vancomycin co-treated with Imipenem] results in decreased expression of SLC51A mRNA CTD PMID:24657338 leflunomide increases expression ISO RGD:1604974 6480464 leflunomide results in increased expression of SLC51A mRNA CTD PMID:28988120 lithocholic acid increases expression ISO RGD:1604974 6480464 Lithocholic Acid results in increased expression of SLC51A mRNA CTD PMID:19562681 , PMID:25055961 lithocholic acid increases expression ISO RGD:1322376 6480464 Lithocholic Acid results in increased expression of SLC51A mRNA CTD PMID:17256725 , PMID:25582706 lithocholic acid multiple interactions ISO RGD:1322376 6480464 Lithocholic Acid inhibits the reaction [NR1H3 protein results in increased expression of SLC51A mRNA] CTD PMID:17256725 lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid binds to VDR protein] which affects the expression of SLC51A mRNA CTD PMID:19562681 methapyrilene decreases methylation ISO RGD:1604974 6480464 Methapyrilene results in decreased methylation of SLC51A intron CTD PMID:30157460 methotrexate increases expression ISO RGD:1604974 6480464 Methotrexate results in increased expression of SLC51A mRNA CTD PMID:24449571 N-Nitrosopyrrolidine decreases expression ISO RGD:1604974 6480464 N-Nitrosopyrrolidine results in decreased expression of SLC51A mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1604974 6480464 Nickel results in increased expression of SLC51A mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol decreases expression ISO RGD:1604974 6480464 methyleugenol results in decreased expression of SLC51A mRNA CTD PMID:32234424 obeticholic acid increases expression ISO RGD:1322376 6480464 obeticholic acid results in increased expression of SLC51A mRNA, obeticholic acid results in increased expression of SLC51A protein CTD PMID:26655953 obeticholic acid increases expression ISO RGD:1604974 6480464 obeticholic acid results in increased expression of SLC51A mRNA CTD PMID:27939613 oleanolic acid decreases expression ISO RGD:1322376 6480464 Oleanolic Acid results in decreased expression of SLC51A mRNA CTD PMID:23948738 paracetamol decreases expression ISO RGD:1604974 6480464 Acetaminophen results in decreased expression of SLC51A mRNA CTD PMID:26690555 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC51A mRNA CTD PMID:33387578 perfluorobutanesulfonic acid multiple interactions ISO RGD:1604974 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorobutanesulfonic acid CTD PMID:26001962 perfluorohexanesulfonic acid multiple interactions ISO RGD:1604974 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorohexanesulfonic acid CTD PMID:26001962 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1604974 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorooctane sulfonic acid CTD PMID:26001962 phenethyl caffeate multiple interactions ISO RGD:1322376 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51A mRNA, GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51A mRNA] CTD PMID:28223344 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLC51A mRNA, Pyrazinamide results in decreased expression of SLC51A protein CTD PMID:27255380 quercetin decreases expression ISO RGD:1604974 6480464 Quercetin results in decreased expression of SLC51A mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:1604974 6480464 Oxyquinoline results in decreased expression of SLC51A mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1604974 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC51A mRNA CTD PMID:23557933 rifampicin increases expression ISO RGD:1604974 6480464 Rifampin results in increased expression of SLC51A mRNA CTD PMID:27199754 ritonavir decreases expression ISO RGD:1604974 6480464 Ritonavir results in decreased expression of SLC51A CTD PMID:26626330 streptozocin multiple interactions ISO RGD:1322376 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of SLC51A mRNA CTD PMID:29382564 sulforaphane decreases expression ISO RGD:1604974 6480464 sulforaphane results in decreased expression of SLC51A mRNA CTD PMID:34767876 tamoxifen affects expression ISO RGD:1322376 6480464 Tamoxifen affects the expression of SLC51A mRNA CTD PMID:17555576 taurochenodeoxycholic acid multiple interactions ISO RGD:1604974 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurochenodeoxycholic Acid more ... CTD PMID:32294204 taurocholic acid multiple interactions ISO RGD:1604974 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid, Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid] CTD PMID:32294204 tetrachloromethane multiple interactions ISO RGD:1322376 6480464 PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of SLC51A mRNA] CTD PMID:16006527 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC51A mRNA, Thioacetamide results in decreased expression of SLC51A protein CTD PMID:26222700 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC51A mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1322376 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51A mRNA CTD PMID:29950665 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1604974 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC51A mRNA CTD PMID:29024780 urethane decreases expression ISO RGD:1604974 6480464 Urethane results in decreased expression of SLC51A mRNA CTD PMID:28818685 ursodeoxycholic acid increases expression ISO RGD:1604974 6480464 Ursodeoxycholic Acid results in increased expression of SLC51A mRNA CTD PMID:25055961 ursodeoxycholic acid increases expression ISO RGD:1322376 6480464 Ursodeoxycholic Acid results in increased expression of SLC51A mRNA CTD PMID:25582706 valproic acid decreases expression ISO RGD:1604974 6480464 Valproic Acid results in decreased expression of SLC51A mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1604974 6480464 Valproic Acid affects the expression of SLC51A mRNA CTD PMID:25979313 vancomycin multiple interactions ISO RGD:1322376 6480464 [Vancomycin co-treated with Imipenem] results in decreased expression of SLC51A mRNA CTD PMID:24657338